MetaCap

Cypherpunk Technologies Stock Forecast

NASDAQ: CYPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.05-0.21 (-6.44%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Pre-market: 2.82 -7.61%

CYPH analyst consensus

Consensus (1 analysts)

none

Avg. price target

$4.90+60.66%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

What analysts say

According to 1 Wall Street analyst covering Cypherpunk Technologies (2026-10-08), 1 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $4.90, with a high estimate of $4.90 and a low estimate of $4.90. The average target implies upside of 60.7% from the current price of $3.05.

The spread between the highest and lowest targets is 0.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CYPH.

Summary generated from market data by MetaCap's automated system. Methodology

Rating distribution

Cypherpunk Technologies analyst rating distribution
RatingAnalystsShare
Strong buy00%
Buy1100%
Hold00%
Sell00%
Strong sell00%

Ratings as of 2026-10-08.

Price target scenarios

Price targets versus the current price
TargetPricevs. current
Low target$4.90+60.66%
Average target$4.90+60.66%
High target$4.90+60.66%

How analysts view Cypherpunk Technologies's peers

Peer analyst targets
CompanyConsensusPriceAvg. targetImplied move
BNTCstrong_buy8.99$24.33+170.63%
RLMDnone3.25$10.75+230.77%
PRLDstrong_buy3.83$9.20+140.21%
ENTAstrong_buy12.37$21.83+76.48%
EBSnone7.07$11.00+55.59%

Related